155 related articles for article (PubMed ID: 26609478)
1. Up-regulated CKS2 promotes tumor progression and predicts a poor prognosis in human colorectal cancer.
Yu MH; Luo Y; Qin SL; Wang ZS; Mu YF; Zhong M
Am J Cancer Res; 2015; 5(9):2708-18. PubMed ID: 26609478
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of cyclin kinase subunit 2 in colorectal cancer.
Yu M; Zhong M; Qiao Z
Oncol Lett; 2013 Sep; 6(3):777-780. PubMed ID: 24137409
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase subunit 2 overexpression promotes tumor progression and predicts poor prognosis in uterine leiomyosarcoma.
Deng Y; Han Q; Mei S; Li H; Yang F; Wang J; Ge S; Jing X; Xu H; Zhang T
Oncol Lett; 2019 Sep; 18(3):2845-2852. PubMed ID: 31452763
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance.
Wang J; Xu L; Liu Y; Chen J; Jiang H; Yang S; Tan H
Int J Clin Exp Pathol; 2014; 7(12):8593-601. PubMed ID: 25674223
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer.
Chen Q; Fu Y; Liu X; Wang P; Dai S; Zhu F; Liu T; Xu W; Wu J
Mol Carcinog; 2023 Dec; 62(12):1947-1959. PubMed ID: 37642304
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
[TBL] [Abstract][Full Text] [Related]
8. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
Xu JH; Wang Y; Xu D
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
[TBL] [Abstract][Full Text] [Related]
9. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Cui R; Shi XY
Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2.
Hua K; Jin J; Zhang H; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 Oct; 49(4):1531-1540. PubMed ID: 27633373
[TBL] [Abstract][Full Text] [Related]
11. High expression of WWP1 predicts poor prognosis and associates with tumor progression in human colorectal cancer.
Chen JJ; Zhang W
Am J Cancer Res; 2018; 8(2):256-265. PubMed ID: 29511596
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer.
Tanaka F; Matsuzaki S; Mimori K; Kita Y; Inoue H; Mori M
Int J Oncol; 2011 Aug; 39(2):361-72. PubMed ID: 21617860
[TBL] [Abstract][Full Text] [Related]
13. High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma.
Yu K; Ji Y; Liu M; Shen F; Xiong X; Gu L; Lu T; Ye Y; Feng S; He J
Front Immunol; 2022; 13():881453. PubMed ID: 35663965
[TBL] [Abstract][Full Text] [Related]
14. EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling.
Li Z; Xue TQ; Yang C; Wang YL; Zhu XL; Ni CF
J Cell Biochem; 2018 Dec; 119(12):10327-10337. PubMed ID: 30129142
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of CKS2 and CD47 expression in patients with gastric cancer who underwent radical gastrectomy.
Zhou Y; Zeng J; Zhou W; Wu K; Tian Z; Shen W
Scand J Immunol; 2022 Oct; 96(4):e13198. PubMed ID: 35703112
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.
Kita Y; Nishizono Y; Okumura H; Uchikado Y; Sasaki K; Matsumoto M; Setoyama T; Tanoue K; Omoto I; Mori S; Owaki T; Ishigami S; Nakagawa H; Tanaka F; Mimori K; Mori M; Natsugoe S
Oncol Rep; 2014 May; 31(5):1986-92. PubMed ID: 24604089
[TBL] [Abstract][Full Text] [Related]
17. CKS2 in human cancers: Clinical roles and current perspectives (Review).
You H; Lin H; Zhang Z
Mol Clin Oncol; 2015 May; 3(3):459-463. PubMed ID: 26137251
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.
Shen DY; Fang ZX; You P; Liu PG; Wang F; Huang CL; Yao XB; Chen ZX; Zhang ZY
Liver Int; 2010 Jan; 30(1):119-25. PubMed ID: 19845855
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of regulator of G-protein signaling 6 in colorectal cancer.
Luo Y; Qin SL; Yu MH; Mu YF; Wang ZS; Zhong M
Biomed Pharmacother; 2015 Dec; 76():147-52. PubMed ID: 26653562
[TBL] [Abstract][Full Text] [Related]
20. High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients.
Yan X; Shan Z; Yan L; Zhu Q; Liu L; Xu B; Liu S; Jin Z; Gao Y
Oncotarget; 2016 Apr; 7(15):19680-92. PubMed ID: 26967242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
